| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $1,150,470 ) |
| | 2023 | 2023 | QUADRIDOX INC. | 4306 SUGAR PINE LN | DURHAM | NC | 27705-7322 | DURHAM | USA | R44EB034645 | Development and evaluation of a combined X-ray transmission and diffraction imaging system for pathology | 000 | 1 | NIH | 9/8/2023 | $887,595 |
| | 2023 | 2023 | QUADRIDOX INC | 4306 SUGAR PINE LN | DURHAM | NC | 27705-7322 | DURHAM | USA | R33CA256102 | Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens | 000 | 3 | NIH | 4/20/2023 | $262,875 |
|
| Issue Date FY: 2022 ( Subtotal = $456,450 ) |
| | 2022 | 2022 | QUADRIDOX INC | 4306 SUGAR PINE LN | DURHAM | NC | 27705-7322 | DURHAM | USA | R33CA256102 | Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens | 003 | 2 | NIH | 9/20/2022 | $184,496 |
| | 2022 | 2022 | QUADRIDOX, INC. | 4306 SUGAR PINE LN | DURHAM | NC | 27705-7322 | DURHAM | USA | R33CA256102 | Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens | 001 | 2 | NIH | 8/29/2022 | $271,954 |
|
|
